AOD-9604 Cycle Length: 8, 12 and 24 Weeks in Research Published Phase 2 research lasted 12 or 24 weeks
For individuals sourcing either compound from unregulated online vendors, additional risks include contamination with unknown substances, incorrect dosing due to inaccurate labelling, and the use of non-sterile injection equipment, which can lead to serious infections including abscess formation or sepsis
No peer-reviewed human clinical trials for 5-Amino-1MQ have been published to date
Linking AHK-Cu to bigger, biocompatible carriers that enhance delivery accuracy and shield it from deterioration is one intriguing approach, drawing inspiration from recent developments in nanomaterial-based treatments (Saha et al., 2024)
Maintain a safe clinical environment and CQC compliance with our sharps bins and disposal systems
Our approach includes the following steps: Your journey begins with an initial consultation with one of our highly qualified healthcare providers